Macrogenics Inc
(NAS:MGNX)
$
4.03
+0.040 (+1%)
Market Cap: 256.16 Mil
Enterprise Value: 138.44 Mil
PE Ratio: 0
PB Ratio: 12.07
GF Score: 47/100 
MacroGenics Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022 / 07:50PM GMT
Release Date Price:
$8.21
(+1.11%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
So first and foremost, thanks for everybody attending. It's the first conference in a couple of years we're back to in person. So thanks for the enthusiasm and support. And thank you so much, Scott, for attending and all your time.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Always a pleasure.
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
Always a pleasure to chat with you.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Same here.
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst
We've only got 25 minutes though. That's the only...
Scott Koenig;Peter Richard Lawson
MacroGenics, Inc. - CEO, President & Director;
Absolutely. So you only get to ask one question, I think.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers